Hanger, Inc. (HNGR)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Hanger, Inc. (HNGR) trades at $18.72. Hanger, Inc. is a leading provider of orthotic and prosthetic (O&P) services in the United States. Sector: Healthcare.
Last analyzed: Mar 16, 2026Analyst Coverage for HNGR: HNGR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HNGR against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
HNGR: 1/1 perspectives are bearish.
Hanger, Inc. (HNGR) Healthcare & Pipeline Overview
Hanger, Inc. is a prominent player in the U.S. orthotic and prosthetic (O&P) services market, operating through its Patient Care and Products & Services segments. The company distinguishes itself through its extensive network of patient care clinics and its comprehensive range of O&P devices and rehabilitation technologies, catering to both patients and O&P providers.
What Is the Investment Thesis for HNGR?
Hanger, Inc. presents a compelling investment case based on its established market position in the O&P services industry and its diversified revenue streams. The company's extensive network of patient care clinics and its comprehensive product offerings provide a stable foundation for growth. With a P/E ratio of 17.21 and a gross margin of 64.5%, Hanger demonstrates financial stability. Key growth catalysts include the increasing demand for O&P services due to the aging population and the rising prevalence of diabetes. However, investors may want to evaluate potential risks such as reimbursement pressures and competition from other O&P providers. The company's beta of 1.36 indicates a higher volatility compared to the market, which should be factored into investment decisions.
Based on FMP financials and quantitative analysis
HNGR Key Highlights
- Hanger operates approximately 760 patient care clinics and 115 satellite locations across 47 states and the District of Columbia as of December 31, 2021.
- The company's gross margin stands at 64.5%, reflecting its ability to maintain profitability in the O&P services market.
- Hanger's P/E ratio is 17.21, indicating its valuation relative to its earnings.
- The company's beta is 1.36, suggesting higher volatility compared to the overall market.
- Hanger's profit margin is 3.7%.
Who Are HNGR's Competitors?
Who Are HNGR's Competitors?
HNGR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AORT Artivion Inc. | $36.24 | +1.14% | 2B | 48 |
| APEN APEN | $9.99 | +0.71% | 580M | 56 |
| ATRI Atrion Corporation | $459.92 | +0.06% | 810M | 38 |
| CDMO CDMO | $12.49 | +0.00% | $798.90M | 38 |
| CMRX Chimerix, Inc. | $8.54 | +0.00% | $801.08M | 50 |
| TOI The Oncology Institute, Inc. | $4.59 | +2.68% | 459M | 61 |
| SLHGP Skylight Health Group Inc. | $12.00 | +0.00% | 61 | |
| EVGRF China Evergrande New Energy Vehicle Group Limited | $0.00 | +0.00% | $2.17M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HNGR's Key Strengths?
- Established market position in the O&P services industry.
- Extensive network of patient care clinics.
- Comprehensive product and service offerings.
- Strong relationships with payors and healthcare providers.
What Are HNGR's Weaknesses?
- Exposure to reimbursement pressures from payors.
- Dependence on skilled clinicians and technicians.
- Potential for product liability claims.
- High beta indicating greater volatility than the market.
What Could Drive HNGR Stock Higher?
- Increasing demand for O&P services due to the aging population and rising prevalence of diabetes.
- Development and adoption of advanced O&P technologies, such as microprocessor-controlled devices and 3D-printed prosthetics.
- Expansion of Hanger's patient care network and product offerings.
- Strategic acquisitions of smaller O&P providers and technology companies.
What Are the Key Risks for HNGR?
- Reimbursement pressures from payors (insurance companies and government healthcare programs).
- Competition from other O&P providers.
- Product liability claims related to O&P devices.
- Economic downturns impacting patient demand and healthcare spending.
- Dependence on skilled clinicians and technicians.
What Are the Growth Opportunities for HNGR?
- Growth opportunity 1: Expansion of Patient Care Network: Hanger can expand its network of patient care clinics and satellite locations to reach underserved markets and increase its patient base. This expansion can be achieved through acquisitions, partnerships, or the establishment of new clinics. The market for O&P services is expected to grow, driven by the aging population and the rising prevalence of diabetes, presenting a significant opportunity for Hanger to increase its market share. Timeline: Ongoing.
- Growth opportunity 2: Development of Advanced O&P Technologies: Hanger can invest in the development of advanced O&P technologies, such as microprocessor-controlled devices and 3D-printed prosthetics, to improve the functionality and comfort of its devices. These technologies can differentiate Hanger from its competitors and attract patients seeking cutting-edge solutions. The market for advanced O&P technologies is growing rapidly, driven by technological advancements and increasing patient demand. Timeline: Ongoing.
- Growth opportunity 3: Expansion of Products & Services Segment: Hanger can expand its Products & Services segment by offering a wider range of O&P parts, componentry, and devices to independent O&P providers. This expansion can be achieved through strategic partnerships with manufacturers and distributors. The market for O&P products and services is large and fragmented, presenting a significant opportunity for Hanger to increase its sales and market share. Timeline: Ongoing.
- Growth opportunity 4: Enhancement of Clinical Programs: Hanger can enhance its evidence-based clinical programs for post-acute rehabilitation to improve patient outcomes and reduce healthcare costs. These programs can be offered to patients at skilled nursing and post-acute facilities, as well as through Hanger's patient care clinics. The market for post-acute rehabilitation services is growing, driven by the aging population and the increasing prevalence of chronic diseases. Timeline: Ongoing.
- Growth opportunity 5: Strategic Acquisitions: Hanger can pursue strategic acquisitions of smaller O&P providers and technology companies to expand its market presence, enhance its product offerings, and gain access to new technologies. Acquisitions can provide Hanger with a competitive advantage and accelerate its growth. The O&P market is consolidating, presenting opportunities for Hanger to acquire complementary businesses. Timeline: Ongoing.
What Opportunities Does HNGR Have?
- Expansion into underserved markets.
- Development of advanced O&P technologies.
- Strategic acquisitions of smaller O&P providers.
- Growth in the aging population and the prevalence of diabetes.
What Threats Does HNGR Face?
- Competition from other O&P providers.
- Changes in reimbursement policies.
- Technological obsolescence.
- Economic downturns.
What Are HNGR's Competitive Advantages?
- Established brand reputation and long operating history (founded in 1861).
- Extensive network of patient care clinics and satellite locations.
- Comprehensive product and service offerings, including custom O&P devices, distribution, and rehabilitation technologies.
- Strong relationships with payors and healthcare providers.
- Proprietary technologies and clinical programs.
What Does HNGR Do?
Founded in 1861 and headquartered in Austin, Texas, Hanger, Inc. has evolved into a leading provider of orthotic and prosthetic (O&P) services in the United States. Originally known as Hanger Orthopedic Group, Inc., the company changed its name in 2012 to reflect its broader range of services and market presence. Hanger operates through two primary segments: Patient Care and Products & Services. The Patient Care segment, operating under the Hanger Clinic brand, specializes in the design, fabrication, and delivery of custom O&P devices. This segment serves patients through an extensive network of patient care clinics and satellite locations across 47 states and the District of Columbia. In addition to direct patient care, the Patient Care segment offers payor network contracting services to other O&P providers. The Products & Services segment focuses on the distribution of O&P parts, componentry, and devices to independent O&P providers. This segment also develops specialized rehabilitation technologies and provides evidence-based clinical programs for post-acute rehabilitation to patients at skilled nursing and post-acute facilities. Furthermore, the Products & Services segment manufactures and sells therapeutic footwear for diabetic patients in the podiatric market. As of December 31, 2021, Hanger operated approximately 760 patient care clinics and 115 satellite locations.
What Products and Services Does HNGR Offer?
- Designs, fabricates, and delivers custom orthotic and prosthetic (O&P) devices.
- Operates a network of patient care clinics and satellite locations.
- Offers payor network contracting services to other O&P providers.
- Distributes O&P parts, componentry, and devices to independent O&P providers.
- Develops specialized rehabilitation technologies.
- Provides evidence-based clinical programs for post-acute rehabilitation.
- Manufactures and sells therapeutic footwear for diabetic patients.
How Does HNGR Make Money?
- Generates revenue from the design, fabrication, and delivery of custom O&P devices through its patient care clinics.
- Earns revenue from the distribution of O&P parts, componentry, and devices to independent O&P providers.
- Receives fees for providing payor network contracting services to other O&P providers.
- Generates revenue from the development and sale of specialized rehabilitation technologies.
- Earns revenue from the manufacture and sale of therapeutic footwear for diabetic patients.
What Industry Does HNGR Operate In?
The U.S. orthotic and prosthetic (O&P) services market is characterized by increasing demand driven by an aging population, rising rates of diabetes, and advancements in O&P technology. Hanger, Inc. operates within this market, competing with other O&P providers such as AORT, APEN, ATRI, CDMO, and CMRX. The industry is subject to regulatory oversight and reimbursement policies, which can impact profitability. Market trends include the adoption of advanced materials and technologies, such as 3D printing and microprocessor-controlled devices, to improve the functionality and comfort of O&P devices.
Who Are HNGR's Key Customers?
- Patients requiring orthotic and prosthetic devices.
- Independent orthotic and prosthetic providers.
- Skilled nursing and post-acute facilities.
- Payors (insurance companies and government healthcare programs).
- Podiatric professionals and diabetic patients.
HNGR Financials
HNGR Latest News
-
12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga · Jul 21, 2022
-
Stocks That Hit 52-Week Lows On Friday
benzinga · Jun 10, 2022
-
Earnings Scheduled For May 4, 2022
benzinga · May 4, 2022
-
Stocks That Hit 52-Week Lows On Thursday
benzinga · Apr 28, 2022
HNGR Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HNGR.
Price Targets
Wall Street price target analysis for HNGR.
HNGR MoonshotScore
What does this score mean?
The MoonshotScore rates HNGR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Who Are HNGR's Competitors?
Leadership: Vinit Asar
CEO
Vinit Asar serves as the Chief Executive Officer of Hanger, Inc. His professional background and specific career history prior to Hanger, Inc. are Unknown. As CEO, he is responsible for the overall strategic direction and operational performance of the company, overseeing a workforce of approximately 5,200 employees. His leadership is crucial in navigating the evolving healthcare landscape and maintaining Hanger's position as a leading provider of orthotic and prosthetic services.
Track Record: Due to limited data, specific achievements and milestones under Vinit Asar's leadership are Unknown. However, his role as CEO necessitates strategic decision-making and execution to drive growth and profitability for Hanger, Inc.
What Investors Ask About Hanger, Inc. (HNGR) — Healthcare
What does Hanger, Inc. do?
Hanger, Inc. is a leading provider of orthotic and prosthetic (O&P) services in the United States. The company operates through two segments: Patient Care and Products & Services. The Patient Care segment owns and operates Hanger Clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations. The Products & Services segment distributes O&P parts, components, and devices to independent O&P providers, develops specialized rehabilitation technologies, and provides evidence-based clinical programs for post-acute rehabilitation.
What do analysts say about HNGR stock?
AI analysis is pending for HNGR. Therefore, a neutral summary of analyst consensus, key valuation metrics, and growth considerations is Unknown. Investors should consult with financial professionals and conduct their own due diligence before making any investment decisions. Further information will be available when the AI analysis is complete.
What are the main risks for HNGR?
Hanger, Inc. faces several risks inherent to the healthcare and O&P services industries. Reimbursement pressures from payors, including insurance companies and government healthcare programs, can impact revenue and profitability. Competition from other O&P providers could erode market share. Product liability claims related to O&P devices pose a financial risk. Economic downturns could reduce patient demand and healthcare spending. The company's dependence on skilled clinicians and technicians creates operational risks related to recruitment and retention.
What are the key factors to evaluate for HNGR?
Evaluating HNGR involves reviewing fundamentals, analyst consensus, and risk factors. Key strength: Established market position in the O&P services industry. Primary risk to monitor: Reimbursement pressures from payors (insurance companies and government healthcare programs). This is not financial advice.
How frequently does HNGR data refresh on this page?
HNGR prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven HNGR's recent stock price performance?
Recent price movement in Hanger, Inc. (HNGR) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established market position in the O&P services industry. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider HNGR overvalued or undervalued right now?
Determining whether Hanger, Inc. (HNGR) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying HNGR?
Before investing in Hanger, Inc. (HNGR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on information available as of 2021-12-31.
- AI analysis is pending, which may provide additional insights.